Based on our results, reliable assessment of one of the culprits in AD namely HP‐tau containing lesions in an interlaboratory setting can be reached when the instructions are simple and clear, the IHC labeling is robust and the lesions are substantial, that is, they have spread to isocortical structures. Here, MAPT is linked to Alzheimer disease.